HHS Seeks Comments on Renewing Cultural Health Training Data Collection
Published Date: 2/20/2026
Notice
Summary
The Department of Health and Human Services’ Office of Minority Health wants your thoughts on keeping their Think Cultural Health info collection going—no changes, just a renewal. This helps health pros sign up for courses and earn credits to better serve diverse communities. You’ve got until April 21, 2026, to share your comments, and there’s no new cost involved.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Time Burden on Health Professionals Quantified
HHS OMH estimates the total annualized respondent burden for the TCH collection is 12,580 hours. This includes 118,352 registrations (3 minutes each → 5,918 hours), 118,352 course/unit evaluations (3 minutes each → 5,918 hours), a 4,208-person follow-up survey (10 minutes each → 701 hours), 15 focus group participants (120 minutes each → 30 hours), and 13 key informant interviews (60 minutes each → 13 hours). OMH reports an overall annual increase of 10,576 hours due to more respondents.
Think Cultural Health Renewal Keeps CE Access
HHS Office of Minority Health is requesting reinstatement without change of the Think Cultural Health information collection (OMB No. 0990-0407), so health and health care professionals can continue to register on the TCH website and earn continuing education credits. The agency is accepting public comments through April 21, 2026, and the collection is being renewed without adding new costs.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16414, Adoption and Foster Care Analysis and Reporting System
This document withdraws a proposed rule that was published in the Federal Register on January 11, 2008. The proposed rule would have amended the Adoption and Foster Care Analysis and Reporting System (AFCARS) regulations at 45 CFR 1355.40 and the appendices to Part 1355 to modify the requirements for States to collect and report data to ACF on children in out-of-home care and in subsidized adoption or guardianship arrangements with the State. This document also withdraws the provision of the 2008 proposed rule that implemented the AFCARS penalty requirements of the Adoption Promotion Act of 2003 (Pub. L. 108-145).
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14709, Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program; Correction
This correction fixes some typos and technical mistakes in the 2027 health insurance rules under the Affordable Care Act. It mainly affects people and organizations involved in health coverage plans by clarifying when the rules take effect and restoring some important regulation details. These fixes take effect on July 20, 2026, ensuring smoother and clearer health plan operations next year.
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-12069, Medicare Program; Strengthening Oversight of Accrediting Organizations (AOs) and Preventing AO Conflicts of Interest, and Related Provisions
This new rule makes sure the groups that check Medicare providers play fair and follow clear rules to avoid conflicts of interest. It updates how psychiatric hospitals are reviewed and tightens rules for providers who lost their Medicare status but want back in. These changes affect Medicare providers and accrediting groups, start June 16, 2027, and aim to keep care safe and trustworthy.
Previous / Next Documents
Previous: 2026-03312, Determination of Regulatory Review Period for Purposes of Patent Extension; SYMVESS
The FDA has set the official review period for SYMVESS, a human biological product, so its patent holder can apply for extra patent time. This affects the company behind SYMVESS and anyone interested in patent extensions. If you think the dates are wrong or want to challenge the company’s diligence, you have until April 20 or August 18, 2026, to speak up—potentially impacting patent length and market exclusivity.
Next: 2026-03315, New Postal Products
The Postal Service has asked for approval of a new deal that changes how some mail services work, especially for competitive products. This affects businesses and customers who use these special mail options, with public comments open until February 24, 2026. The changes could mean new pricing or service tweaks, so keep an eye out if you use these postal products!